Global Medical Cannabis Market Report 2023 to 2030 – Growing Research Activities and Clinical Trials on Cannabis Drives Growth – ResearchAndMarkets.com

- Advertisement -

DUBLIN–(BUSINESS WIRE)–The “Medical Cannabis Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering.

The global medical cannabis market is expected to grow at a CAGR of around 13.3% during 2023-2030.

- Advertisement -

This report on global medical cannabis provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the medical cannabis market by segmenting the market based on species, molecule, end user, application, and region.

Also, detailed profiles of companies operating in the global medical cannabis market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

READ MORE:  Ketamine-assisted Wellness: The Center for New Growth Partners With Humboldt Social to Offer Psychotherapy Retreats

Companies Mentioned

- Advertisement -
  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Canopy growth Corporation
  • Green thumb Industries
  • Medical Marijuana Inc.
  • Medmen
  • Stenocare
  • Terra Tech Corp.
  • The Cronos Group
  • Tikum Olam
  • VIVO cannabis Inc.

Market Dynamics

Drivers

  • Growing research activities and clinical trials on cannabis
  • Rise in social acceptance of Cannabis.

Challenges

- Advertisement -
  • Legalization in most of the countries is not yet done.
  • Medical usage & research requires trained & authorized staff but lack of this is hampering its growth.

Historical & Forecast Period

  • Base Year: 2022
  • Historical Period: 2018-2022
  • Forecast Period: 2023-2030

Market Segmentation

by Species

  • Indica
  • Sativa
  • Hybrid

by Molecule

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others
READ MORE:  POSaBIT Continues Eastward Expansion, Goes Live with Point of Sale System in Vermont

by End User

  • Pharmaceutical Industry
  • Research & Development centres
  • Others

by Applications

  • Arthritis
  • Cancer
  • Depression
  • Epilepsy
  • Migraine
  • Others

by Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/sqmccu-cannabis?w=4.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

- Advertisement -

Latest News

Related articles